Medpace Holdings Inc
Closed
SectorHealthcare
584.94 0.72
Overview
Share price change
24h
Min
584.94
Max
591.87
Income | -2.5M 121M |
|---|---|
Sales | 727K 707M |
P/E Sector Avg | 34.721 56.597 |
EPS | 4.25 |
Profit margin | 17.158 |
Employees | 6,500 |
EBITDA | -21M 134M |
Next Earnings | 21 Oct 2026 |
|---|
Market Cap | 1.4B 17B |
|---|---|
Previous open | 584.22 |
Previous close | 584.94 |
News Sentiment
By Acuity
50%
50%
126 / 339 Healthcare
Medpace Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Medpace Holdings Inc Forecast
Sentiment
By Acuity
126 / 339 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.